These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2575832)

  • 1. Selective vulnerability of pigmented dopaminergic neurons in Parkinson's disease.
    Hirsch EC; Graybiel AM; Agid Y
    Acta Neurol Scand Suppl; 1989; 126():19-22. PubMed ID: 2575832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease.
    Hirsch E; Graybiel AM; Agid YA
    Nature; 1988 Jul; 334(6180):345-8. PubMed ID: 2899295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased M-calpain expression in the mesencephalon of patients with Parkinson's disease but not in other neurodegenerative disorders involving the mesencephalon: a role in nerve cell death?
    Mouatt-Prigent A; Karlsson JO; Agid Y; Hirsch EC
    Neuroscience; 1996 Aug; 73(4):979-87. PubMed ID: 8809817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunocytochemical quantification of tyrosine hydroxylase at a cellular level in the mesencephalon of control subjects and patients with Parkinson's and Alzheimer's disease.
    Kastner A; Hirsch EC; Herrero MT; Javoy-Agid F; Agid Y
    J Neurochem; 1993 Sep; 61(3):1024-34. PubMed ID: 8103078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content?
    Kastner A; Hirsch EC; Lejeune O; Javoy-Agid F; Rascol O; Agid Y
    J Neurochem; 1992 Sep; 59(3):1080-9. PubMed ID: 1494900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP?
    Herrero MT; Hirsch EC; Kastner A; Ruberg M; Luquin MR; Laguna J; Javoy-Agid F; Obeso JA; Agid Y
    Neuroscience; 1993 Sep; 56(2):499-511. PubMed ID: 8247275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catecholaminergic neurons in the parabrachial nucleus of normal individuals and patients with idiopathic Parkinson's disease.
    Goto S; Hirano A
    Ann Neurol; 1991 Aug; 30(2):192-6. PubMed ID: 1680303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional distribution of monoamine vesicular uptake sites in the mesencephalon of control subjects and patients with Parkinson's disease: a postmortem study using tritiated tetrabenazine.
    Thibaut F; Faucheux BA; Marquez J; Villares J; Menard JF; Agid Y; Hirsch EC
    Brain Res; 1995 Sep; 692(1-2):233-43. PubMed ID: 8548309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanin, tyrosine hydroxylase, calbindin and substance P in the human midbrain and substantia nigra in relation to nigrostriatal projections and differential neuronal susceptibility in Parkinson's disease.
    Gibb WR
    Brain Res; 1992 May; 581(2):283-91. PubMed ID: 1382801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson's disease?
    Hartmann A; Michel PP; Troadec JD; Mouatt-Prigent A; Faucheux BA; Ruberg M; Agid Y; Hirsch EC
    J Neurochem; 2001 Mar; 76(6):1785-93. PubMed ID: 11259496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inverse relationship between the contents of neuromelanin pigment and the vesicular monoamine transporter-2: human midbrain dopamine neurons.
    Liang CL; Nelson O; Yazdani U; Pasbakhsh P; German DC
    J Comp Neurol; 2004 May; 473(1):97-106. PubMed ID: 15067721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic MPTP treatment reproduces in baboons the differential vulnerability of mesencephalic dopaminergic neurons observed in Parkinson's disease.
    Varastet M; Riche D; Maziere M; Hantraye P
    Neuroscience; 1994 Nov; 63(1):47-56. PubMed ID: 7898660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of non-phosphorylated neurofilament immunoreactivity, with preservation of tyrosine hydroxylase, in surviving substantia nigra neurons in Parkinson's disease.
    Gai WP; Vickers JC; Blumbergs PC; Blessing WW
    J Neurol Neurosurg Psychiatry; 1994 Sep; 57(9):1039-46. PubMed ID: 7916375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional dopamine transporter gene expression in the substantia nigra from control and Parkinson's disease brains.
    Counihan TJ; Penney JB
    J Neurol Neurosurg Psychiatry; 1998 Aug; 65(2):164-9. PubMed ID: 9703165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide synthase and neuronal vulnerability in Parkinson's disease.
    Hunot S; Boissière F; Faucheux B; Brugg B; Mouatt-Prigent A; Agid Y; Hirsch EC
    Neuroscience; 1996 May; 72(2):355-63. PubMed ID: 8737406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific A10 dopaminergic nuclei in the midbrain degenerate in Parkinson's disease.
    McRitchie DA; Cartwright HR; Halliday GM
    Exp Neurol; 1997 Mar; 144(1):202-13. PubMed ID: 9126172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does the calcium binding protein calretinin protect dopaminergic neurons against degeneration in Parkinson's disease?
    Mouatt-Prigent A; Agid Y; Hirsch EC
    Brain Res; 1994 Dec; 668(1-2):62-70. PubMed ID: 7704619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glia protects neurons against extracellular human neuromelanin.
    Depboylu C; Matusch A; Tribl F; Zoriy M; Michel PP; Riederer P; Gerlach M; Becker S; Oertel WH; Höglinger GU
    Neurodegener Dis; 2007; 4(2-3):218-26. PubMed ID: 17596716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why are nigral catecholaminergic neurons more vulnerable than other cells in Parkinson's disease?
    Hirsch EC
    Ann Neurol; 1992; 32 Suppl():S88-93. PubMed ID: 1510386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.